MedTrace Logo

Comparison of 5G-Mobile Stroke Unit With Standard EMS for Acute Ischemic Stroke

NCT06943885 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 952

Last updated 2025-05-14

No results posted yet for this study

Summary

While Mobile Stroke Units (MSUs) are considered as a relatively new model for acute stroke treatment, 5G Mobile Stroke Units (5G MSUs) have already come into service for stroke treatment in some parts of China. Since limited evidence has been found to suggest their advantages over conventional Emergency Medical Services (EMS), well-conducted clinical studies are required to further assess their effectiveness and safety. This study aims to evaluate whether 5G MSUs outperform standard management (SM) by EMS in terms of functional outcomes of acute ischemic stroke (AIS) patients within 4.5 hours after symptom onset in urban and rural areas of China.

Conditions

  • Acute Ischemic Stroke

Interventions

OTHER

5G Mobile Stroke Unit Management

5G MSU is a specialized stroke ambulance equipped with point of care lab, CT scanner, Telemedicine, allowing patients to receive intravenous thrombolysis.

OTHER

Standard Management

A regular ambulance. The standard management by EMS includes Electrocardiographic（ECG）monitoring, blood glucose management, airway, respiration, and blood pressure control, complication management, intravenous access establishment and other emergency measures.

Sponsors & Collaborators

  • Beijing Emergency Medical Center

    lead OTHER

Principal Investigators

  • Dou Li, MD · Beijing Emergency Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-25
Primary Completion
2028-10-31
Completion
2029-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06943885 on ClinicalTrials.gov